Consensus Statements on the Clinical Practice for Patients With Fontan-Associated Liver Disease

The Fontan procedure has been transformative for patients with univentricular physiology. By using a single ventricle as the systemic pump and relying on passive venous return to drive pulmonary circulation, Fontan circulation alleviates cyanosis and heart failure, allowing children to engage in normal activities during school and adolescence. Nevertheless, Fontan circulation is characterized by chronically elevated systemic venous pressure, which leads to systemic venous congestion and long-term multiorgan effects. Fontan-associated liver disease (FALD) is now recognized as a major long-term complication. Approximately 50% of patients develop hepatic abnormalities within 10–20 years after surgery, and some progress to cirrhosis and hepatocellular carcinoma (HCC). Despite this risk, strategies to identify individuals at high risk for early HCC and to provide better prognostic information remain limited. This article compiles knowledge from congenital heart disease specialists and hepatologists on FALD, including areas where evidence is limited. By facilitating early diagnosis, structured follow-up, and multidisciplinary management of FALD, this initiative aims to improve outcomes, build a nationwide clinical experience, and ultimately support the development of formal, evidence-based guidelines for FALD management.

Authors

Institutions

Publication Details

Journal
Circulation Journal
Published
2026-11-16
DOI
https://doi.org/10.1253/circj.cj-26-0698
Primary Topic
Congenital Heart Disease Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Consensus Statements on the Clinical Practice for Patients With Fontan-Associated Liver Disease

Teiji Akagi, Ryotaro Sakamori, Jun Muneuchi, Norihisa Toh et al.
Circulation Journal
Congenital Heart Disease Studies
article

Consensus Statements on the Clinical Practice for Patients With Fontan-Associated Liver Disease

Teiji Akagi, Ryotaro Sakamori, Jun Muneuchi, Norihisa Toh, Satoko Ohfuji, Tomoharu Yoshizumi, Ryo Inuzuka, 良介 建石, Hideo Ohuchi, Hironori Kusano, Daisuke Tokuhara, Hiroyuki Yamagishi, Tomomi Kogiso, Tatsuya Kanto
article en

Abstract

The Fontan procedure has been transformative for patients with univentricular physiology. By using a single ventricle as the systemic pump and relying on passive venous return to drive pulmonary circulation, Fontan circulation alleviates cyanosis and heart failure, allowing children to engage in normal activities during school and adolescence. Nevertheless, Fontan circulation is characterized by chronically elevated systemic venous pressure, which leads to systemic venous congestion and long-term multiorgan effects. Fontan-associated liver disease (FALD) is now recognized as a major long-term complication. Approximately 50% of patients develop hepatic abnormalities within 10–20 years after surgery, and some progress to cirrhosis and hepatocellular carcinoma (HCC). Despite this risk, strategies to identify individuals at high risk for early HCC and to provide better prognostic information remain limited. This article compiles knowledge from congenital heart disease specialists and hepatologists on FALD, including areas where evidence is limited. By facilitating early diagnosis, structured follow-up, and multidisciplinary management of FALD, this initiative aims to improve outcomes, build a nationwide clinical experience, and ultimately support the development of formal, evidence-based guidelines for FALD management.

Circulation Journal
Kurume University (JP), Kyushu University (JP), Okayama University (JP), Wakayama Medical University (JP), Osaka National Hospital (JP), National Center for Global Health and Medicine (JP), Kurume University Hospital (JP), Okayama University Hospital (JP), University of Tokyo Hospital (JP), National Cerebral and Cardiovascular Center (JP), Kyushu Hospital (JP), Center for Global Health (US), Sakakibara Hospital (JP), Japan Community Healthcare Organization (JP), Tokyo Women's Medical University (JP), Tokyo Metropolitan Children's Medical Center (JP), Osaka Metropolitan University (JP), Institute of Gastroenterology, Tokyo Women's Medical University (JP), National Institute of Global Health and Medicine (JP), Japan Institute for Health Security (JP), National Cerebral and Cardiovascular Center Hospital (JP), The University of Tokyo (JP)
Tokyo Women's Medical University
Good health and well-being
Congenital Heart Disease Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon